Transoral Robotic Surgery for Oropharyngeal Carcinoma and .ppt

Transoral Robotic Surgery for Oropharyngeal Carcinoma and .ppt

  1. 1、本文档共38页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Transoral Robotic Surgery for Oropharyngeal Carcinoma and .ppt

* At one and two year time points for at risk patients, overall survival was 55/58 (94.8%) and 33/41 (80.5%), respectively. At one and two year time points for at risk patients, disease specific survival was 55/56 (98%) and 33/36 (91.7%) * At one and two year time points for at risk patients, overall survival was 55/58 (94.8%) and 33/41 (80.5%), respectively. At one and two year time points for at risk patients, disease specific survival was 55/56 (98%) and 33/36 (91.7%) * At one and two year time points for at risk patients, overall survival was 55/58 (94.8%) and 33/41 (80.5%), respectively. At one and two year time points for at risk patients, disease specific survival was 55/56 (98%) and 33/36 (91.7%) * * 12 surgery alone, 13 surgery plus radiation, 31 (one patient had radiation prior for lymphoma, 1 patient had liver mets diagnosed shortly after treatment) 3 patients recommended adjuvant therapy, but refused * Overall survival as a function of HPV status (1/blue line, HPV-, 2/green line, HPV+) 31 patients assessed; 22 HPV+ and 9 patients HPV- * * AngKK JCO23(13)2005 : 50 OP, 30% ShileySG-OtoHNS2006, 143,3,455-9: 48% G tube required * * * * * Overall survival with respect to HPV status P=0.87 (log rank) Comparison of outcomes related to HPV status 30: Fakhry et al. J. Natl Cancer Inst. 2008 100:261-269. 31: Worden et al. J Clin Oncol; 26:3138-3146 2008 Swallowing function There is a wide range of cited percentage of people after chemoradiation requiring gastrostomy tube. This is cited from 3% to approximately 50%.5,34,35 Ang et al cited the long term need for gastrostomy tubes in 30% of those with OPSCC treated with chemoradiation.34 Shiley et al cited the need for gastrostomy tube in 48% of those with OPSCC treated with chemoradiation.35 In our cohort 91% (50/55) of at risk patients had the gastrostomy tube removed. Conclusions TORS appears to be oncologically sound, with adequate margins of resection as well as satisfactory preliminary overall and dis

文档评论(0)

lmother_lt + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档